Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xoma Royalty Corporation
(NQ:
XOMA
)
29.75
+0.61 (+2.09%)
Streaming Delayed Price
Updated: 10:40 AM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Xoma Royalty Corporation
< Previous
1
2
Next >
XOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q2 2024
August 13, 2024
XOMA stock results show that XOMA missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base
July 09, 2024
FDA's Genetic Metabolic Diseases Advisory Committee will review Zevra Therapeutics' arimoclomol for Niemann-Pick disease type C on August 2. PDUFA decision expected by September 21.
Via
Benzinga
Exposures
Product Safety
Demystifying XOMA: Insights From 5 Analyst Reviews
July 09, 2024
Via
Benzinga
3 Crazy Good Stocks to Buy With $500 Right Now
June 12, 2024
For investors with only a little money to spare, these three supercharged stocks represent an outrageous opportunity for future growth.
Via
InvestorPlace
Peeling Back The Layers: Exploring XOMA Through Analyst Insights
May 31, 2024
Via
Benzinga
XOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q1 2024
May 09, 2024
XOMA stock results show that XOMA missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Cracking The Code: Understanding Analyst Reviews For XOMA
April 29, 2024
Via
Benzinga
Recap: XOMA Q4 Earnings
March 08, 2024
Via
Benzinga
XOMA's Return On Capital Employed Insights
May 24, 2023
Via
Benzinga
XOMA Stock Earnings: XOMA Misses EPS, Misses Revenue for Q4 2023
March 08, 2024
XOMA stock results show that XOMA missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma
February 16, 2024
XOMA acquires Kinnate Biopharma for $2.3352 per share, with potential additional cash. The acquisition is expected to close in April 2024.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 01, 2023
On Friday, 57 companies reached new 52-week lows.
Via
Benzinga
XOMA Earnings Perspective: Return On Capital Employed
March 15, 2023
Via
Benzinga
XOMA's Return On Capital Employed Insights
November 24, 2022
Via
Benzinga
Starbucks And 3 Other Stock Insiders Are Buying
September 19, 2022
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
Recap: XOMA Q4 Earnings
March 08, 2022
XOMA (NASDAQ:XOMA) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
August 28, 2023
During Monday, 102 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 27, 2023
During Thursday, 56 stocks hit new 52-week lows.
Via
Benzinga
Arimoclomol and Aldoxorubicin Acquisition to Bolster XOMA's Revenue Growth: Analyst
June 22, 2023
Earlier today, XOMA Corporation (NASDAQ: XOMA) acquired the royalty and milestone rights associated with two assets from LadRx Corporation: arimoclomol for Niemann-Pick disease type C, and...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
Recap: XOMA Q1 Earnings
May 09, 2023
XOMA (NASDAQ:XOMA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by 96.0%,...
Via
Benzinga
XOMA: Q1 Earnings Insights
May 09, 2023
XOMA (NASDAQ:XOMA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by 96.0%,...
Via
Benzinga
XOMA: Q3 Earnings Insights
November 03, 2022
XOMA (NASDAQ:XOMA) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:45 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 08, 2022
On Thursday, 168 companies reached new 52-week lows.
Via
Benzinga
XOMA Earnings Perspective: Return On Capital Employed
May 27, 2022
Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q1 sales of $3.11 million. Earnings fell to a loss of $2.28 million, resulting in a 107.64% decrease from last quarter. In Q4, XOMA earned $29.84 million,...
Via
Benzinga
XOMA's Return On Capital Employed Insights
March 10, 2022
According to Benzinga Pro, during Q4, XOMA (NASDAQ:XOMA) earned $29.84 million, a 772.77% increase from the preceding quarter. XOMA also posted a total of $35.94 million in sales...
Via
Benzinga
50 Biggest Movers From Yesterday
January 06, 2022
Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 04, 2022
During Wednesday's trading, 435 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 05, 2022
Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is...
Via
Benzinga
XOMA's Return On Capital Employed Overview
November 08, 2021
Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q3 sales of $940.00 thousand. Earnings fell to a loss of $3.35 million, resulting in a 9.17% decrease from last quarter. In Q2,...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.